Clomipramine concentration as a predictor of delayed response: A naturalistic study

European Journal of Clinical Pharmacology

Volumn 54, Issue 12, 1999, Pages 895-902

  Gex Fabry, M ^a   Balant Gorgia, A E ^b   Balant, L P ^a  

^a Department of Psychiatry   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Clomipramine; Concentration effect relationship; Naturalistic study

Indexed keywords

CLOMIPRAMINE; DRUG METABOLITE; NORCLOMIPRAMINE;

ADULT; ARTICLE; CONCENTRATION RESPONSE; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME;

EID: 0033043227     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050572     Document Type: Article

References (35)

1. Blacker CVR, Mortimore C (1996) Randomized controlled trials and naturalistic data: time for a change? Hum Psychopharmacol 11: 353-363
2. Linden M, Baier D, Beitinger H, Kohnen R, Osterheider M, Philipp M, Reimitz DE, Schaaf B, Weber HJ (1997) Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. Pharmacopsychiatry 30 [suppl]: 65-70
3. Laska EM, Siegel C (1995) Characterizing onset in psychopharmacological clinical trials. Psychopharmacol Bull 31: 29-35
4. Derivan AT (1995) Antidepressants: can we determine how quickly they work? Issues from the literature. Psychopharmacol Bull 31: 23-28
5. Overall JE (1995) Justifying a "fast acting" claim for antidepressant drugs. Psychopharmacol Bull 31: 45-55
6. Soares JC, Gershon S (1996) Prospects for the development of new treatments with a rapid onset of action in affective disorders. Drugs 52: 477-482
7. Montgomery SA (1997) Fast-onset antidepressants. Int Clin Psychopharmacol 12 [suppl 3]: S1-S5
8. Stassen HH, Delini-Stula A, Angst J (1993) Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol 3: 127-135
9. Stassen HH, Angst J, Delini-Stula A (1994) Severity at baseline and onset of improvement in depression. Meta-analysis of imipramine and moclobemide versus placebo. Eur Psychiatry 9: 129-136
10. Stassen HH, Angst J, Delini-Stula A (1997) Onset of action under antidepressant treatment. Eur Psychiatry 12: 163-165
11. Quitkin FM, Rabkin JG, Ross D, Stewart JW (1984) Identification of true drug response to antidepressants. Use of pattern analysis. Arch Gen Psychiatry 41: 782-786
12. Quitkin FM, Rabkin JD, Markowitz JM, Stewart JW, McGrath PJ, Harrison W (1987) Use of pattern analysis to identify true drug response. A replication. Arch Gen Psychiatry 44: 259-264
13. Quitkin FM, McGrath PJ, Rabkin JG, Stewart JW, Harrison W, Ross DC, Tricamo E, Fleiss J, Markowitz J, Klein DF (1991) Different types of placebo response in patients receiving antidepressants. Am J Psychiatry 148: 197-203
14. Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, Ross DC, Tricamo E, Fleiss J, Markowitz J, Klein DF (1991) Heterogeneity of clinical response during placebo treatment. Am J Psychiatry 148: 193-196
15. Quitkin FM, Stewart JW, McGrath PJ, Nunes E, Ocepek-Welikson K, Tricamo E, Rabkin JG, Klein DF (1993) Further evidence that a placebo response to antidepressants can be identified. Am J Psychiatry 150: 566-570
16. Montgomery SA (1995) Are 2-week trials sufficient to indicate efficacy? Psychopharmacol Bull 31: 41-44
17. Perry PJ, Pfohl BM, Holstad SG (1987) The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis. Clin Pharmacokinet 13: 381-392
18. Perry PJ, Zeilmann C, Arndt S (1994) Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol 14: 230-240
19. Faravelli C, Ballerini A, Ambonetti A, Broadhurst AD, Das M (1984) Plasma levels and clinical response during treatment with clomipramine. J Affect Disord 6: 95-107
20. Balant-Gorgia AE, Gex-Fabry M, Balant LP (1991) Clinical pharmacokinetics of clomipramine. Clin Pharmacokinet 20: 447-462
21. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389
22. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 76 [suppl 334]: 1-100
23. Hamilton M (1969) Diagnosis and rating of anxiety. Br J Psychiatry (special publication): 76-79
24. Kuss HJ, Jungkunz G (1986) Nonlinear pharmacokinetics of chlorimipramine after infusion and oral administration in patients. Prog Neuropsychopharmacol Biol Psychiatry 10: 739-748
25. Balant-Gorgia AE, Balant LP, Garrone G (1989) High blood concentrations of imipramine or clomipramine and therapeutic failure : a case report study using drug monitoring data. Ther Drug Monit 11: 415-420
26. Greenhouse JB, Stangl D, Bromberg J (1989) An introduction to survival analysis: statistical methods for analysis of clinical trial data. J Consult Clin Psychol 57: 536-544
27. Feinstein AR (1985) Clinical epidemiology. The architecture of clinical research. WB Saunders, Philadelphia
28. Murphy JM, Berwick DM, Weinstein MC, Borus JF, Budman SH, Klerman GL (1987) Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry 44: 550-555
29. Leber P (1995) Speed of onset. Psychopharmacol Bull 31: 37-40
30. Prien RF, Carpenter LL, Kupfer DJ (1991) The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature. Arch Gen Psychiatry 48: 796-800
31. Müller H, Möller HJ (1997) Methodological considerations and empirical data to the onset of efficacy of antidepressants and to the prediction of therapy outcome. Eur Psychiatry 12: 177-182
32. Derivan A, Entsuah AR, Kikta D (1995) Venlafaxine: measuring the onset of antidepressant action. Psychopharmacol Bull 31: 439-447
33. Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M (1995) Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 152: 1500-1503
34. Quitkin FM, McGrath PJ, Stewart JW, Ocepek-Welikson K, Taylor BP, Nunes E, Deliyannides D, Agosti V, Donovan SJ, Petkova E, Klein DF (1996) Chronological milestones to guide drug change. When should clinicians switch antidepressants? Arch Gen Psychiatry 53: 785-792
35. Beaumont G, Baldwin D, Lader M (1996) A criticism of the practice of prescribing subtherapeutic doses of antidepressants for the treatment of depression. Hum Psychopharmacol 11: 283-291